A detailed history of Jupiter Asset Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Jupiter Asset Management LTD holds 159,927 shares of VRTX stock, worth $65.3 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
159,927
Previous 585 27237.95%
Holding current value
$65.3 Million
Previous $274,000 27045.26%
% of portfolio
0.68%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$460.0 - $505.78 $73.3 Million - $80.6 Million
159,342 Added 27237.95%
159,927 $74.4 Million
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $35.4 Million - $43.8 Million
-90,194 Reduced 99.36%
585 $274,000
Q1 2024

May 10, 2024

SELL
$407.69 - $446.08 $29.6 Million - $32.4 Million
-72,637 Reduced 44.45%
90,779 $37.9 Million
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $40.2 Million - $48.1 Million
117,210 Added 253.67%
163,416 $66.5 Million
Q3 2023

Nov 09, 2023

BUY
$338.18 - $362.46 $123,773 - $132,660
366 Added 0.8%
46,206 $16.1 Million
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $39.4 Million - $44.1 Million
-125,179 Reduced 73.2%
45,840 $16.1 Million
Q1 2023

May 10, 2023

BUY
$283.23 - $323.1 $11.5 Million - $13.1 Million
40,504 Added 31.03%
171,019 $53.9 Million
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $11.1 Million - $12.5 Million
38,968 Added 42.57%
130,515 $37.7 Million
Q3 2022

Nov 10, 2022

SELL
$273.83 - $305.53 $9.17 Million - $10.2 Million
-33,485 Reduced 26.78%
91,547 $26.5 Million
Q2 2022

Aug 10, 2022

SELL
$234.96 - $292.55 $231,435 - $288,161
-985 Reduced 0.78%
125,032 $35.2 Million
Q1 2022

May 11, 2022

BUY
$221.42 - $260.97 $27.2 Million - $32.1 Million
123,034 Added 4124.51%
126,017 $32.9 Million
Q4 2021

Feb 11, 2022

SELL
$177.01 - $223.45 $53.8 Million - $67.9 Million
-303,880 Reduced 99.03%
2,983 $664,000
Q3 2021

Nov 10, 2021

BUY
$181.39 - $202.99 $47.2 Million - $52.9 Million
260,450 Added 561.16%
306,863 $55.7 Million
Q2 2021

Aug 10, 2021

BUY
$187.49 - $221.1 $8.7 Million - $10.3 Million
46,413 New
46,413 $9.36 Million
Q1 2021

May 12, 2021

SELL
$207.02 - $241.31 $11.1 Million - $13 Million
-53,800 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$207.01 - $276.09 $5.42 Million - $7.23 Million
26,174 Added 94.74%
53,800 $12.7 Million
Q3 2020

Nov 10, 2020

BUY
$255.65 - $303.1 $7.06 Million - $8.37 Million
27,626 New
27,626 $7.51 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.